| scholarly article | Q13442814 |
| P2093 | author name string | Guenther Boden | |
| Carol Homko | |||
| Jerzy W Kolaczynski | |||
| Carolyn Jimenez | |||
| Antonio Deluzio | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacokinetics | Q323936 |
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 2027-2031 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Diabetes Care | Q5270111 |
| P1476 | title | Comparison of insulin aspart and lispro: pharmacokinetic and metabolic effects | |
| P478 | volume | 26 |
| Q38889745 | 20 Years of insulin lispro in pediatric type 1 diabetes: a review of available evidence |
| Q44511634 | A combined insulin reduction and carbohydrate feeding strategy 30 min before running best preserves blood glucose concentration after exercise through improved fuel oxidation in type 1 diabetes mellitus |
| Q36019817 | A critical appraisal of the role of insulin analogues in the management of diabetes mellitus |
| Q43055962 | Blood glucose responses to reductions in pre-exercise rapid-acting insulin for 24 h after running in individuals with type 1 diabetes. |
| Q35684842 | Cell therapies for type 1 diabetes mellitus |
| Q30424297 | Closed-loop insulin delivery utilizing pole placement to compensate for delays in subcutaneous insulin delivery |
| Q55281492 | Comparison of Efficacy and Safety of Lispro and Aspart Evaluated by Continuous Glucose Monitoring System in Patients with Newly Diagnosed Type 2 Diabetes. |
| Q35703026 | Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations |
| Q88719333 | Cyclic Peptides that Govern Signal Transduction Pathways: From Prokaryotes to Multi-Cellular Organisms |
| Q30370001 | Design and Evaluation of a Robust PID Controller for a Fully Implantable Artificial Pancreas. |
| Q34351640 | Dose-dependent delay of the hypoglycemic effect of short-acting insulin analogs in obese subjects with type 2 diabetes: a pharmacokinetic and pharmacodynamic study |
| Q42607670 | Establishing a continuous glucose monitoring program |
| Q38030454 | Evolution of insulin development: focus on key parameters |
| Q41260941 | Glargine and degludec: Solution behaviour of higher dose synthetic insulins. |
| Q53686525 | Impact of an interchange program to support use of insulin pens. |
| Q56744264 | Impact of pre-exercise rapid-acting insulin reductions on ketogenesis following running in Type 1 diabetes |
| Q28085428 | Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical Experience |
| Q37153705 | Insulin analog preparations and their use in children and adolescents with type 1 diabetes mellitus |
| Q38692387 | Insulin analogues in type 1 diabetes mellitus: getting better all the time |
| Q35871158 | Insulin aspart: a review of its use in the management of type 1 or 2 diabetes mellitus |
| Q41762382 | Insulin glulisine in the management of diabetes |
| Q51468804 | Insulin glulisine: a faster onset of action compared with insulin lispro. |
| Q37957176 | Insulin pump therapy for pregnancy: a primer |
| Q48095280 | Insulin regimens for newly diagnosed children with type 1 diabetes mellitus in Australia and New Zealand: A survey of current practice. |
| Q51313300 | Insulin therapy in children and adolescents with type 1 diabetes. |
| Q36793050 | Intensive insulin therapy in pregnancy: strategies for successful implementation in pregestational diabetes mellitus |
| Q37875678 | MATHEMATICAL MODELS OF SUBCUTANEOUS INJECTION OF INSULIN ANALOGUES: A MINI-REVIEW |
| Q37203256 | Management of diabetic ketoacidosis in children and adolescents |
| Q51567062 | Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy. |
| Q58614459 | Modeling the acute effects of exercise on insulin kinetics in type 1 diabetes |
| Q36795634 | New therapeutic options for treating type-2 diabetes: a review of insulin analogs and premixed insulin analogs |
| Q27672533 | Non-equivalent Role of Inter- and Intramolecular Hydrogen Bonds in the Insulin Dimer Interface |
| Q47769561 | Optimal prandial timing of bolus insulin in diabetes management: a review. |
| Q36554243 | Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes? |
| Q37202896 | Practical strategies to improve treatment of type 2 diabetes |
| Q36909524 | Premixed insulin treatment for type 2 diabetes: analogue or human? |
| Q35642529 | Rapid model exploration for complex hierarchical data: application to pharmacokinetics of insulin aspart |
| Q24246326 | Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus |
| Q34537345 | Systemically modeling the dynamics of plasma insulin in subcutaneous injection of insulin analogues for type 1 diabetes. |
| Q37982891 | The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences |
| Q35752776 | The safety and efficacy of insulin analogs in pregnancy |
| Q35907234 | The use of bolus insulin and advancing insulin therapy in type 2 diabetes |
| Q38578266 | Towards a Physiological Prandial Insulin Profile: Enhancement of Subcutaneously Injected Prandial Insulin Using Local Warming Devices |
| Q36127642 | Two Cases of Allergy to Insulin in Gestational Diabetes. |
| Q42735600 | Update on mathematical modeling research to support the development of automated insulin delivery systems |
| Q30416614 | Use of a food and drug administration-approved type 1 diabetes mellitus simulator to evaluate and optimize a proportional-integral-derivative controller |
Search more.